Synapse - Ai Ni

Search Within

Ai Ni

Results (99)

Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228

Journal Article

Paik, P. K.; Fan, P. D.; Qeriqi, B.; Namakydoust, A.; Daly, B.; Ahn, L.; Kim, R.; Plodkowski, A.; Ni, A.; Chang, J.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

The impact of anti-CD20-based therapy on hypogammaglobulinemia in patients with follicular lymphoma

Journal Article

Fischer, T.; Ni, A.; Bantilan, K. S.; Soumerai, J. D.; Alperovich, A.; Batlevi, C.; Younes, A.; Zelenetz, A. D.
Leukemia and Lymphoma (2022)

Fulltext@MSK | Save

Zanubrutinib, obinutuzumab, and venetoclax in chronic lymphocytic leukemia: Early MRD kinetics define a high-risk patient cohort with delayed bone marrow undetectable MRD and earlier post-treatment MRD recurrence

Meeting Abstract

Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E. P.; Barnes, J. A.; Hamilton, A.; more...
Blood (2021)

Fulltext@MSK | Save

Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: A multicentre, single-arm, phase 2 trial

Journal Article

Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V. E.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; more...
The Lancet Haematology (2021)

Fulltext@MSK | Save

Time from diagnosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma

Journal Article

Soumerai, J. D.; Ni, A.; Alperovich, A.; Batlevi, C.; Bantilan, K. S.; Fischer, T.; Copeland, A. R.; Smith, K.; Ying, Z.; Younes, A.; more...
Leukemia and Lymphoma (2020)

Fulltext@MSK | Save

Follicular lymphoma in the modern era: Survival, treatment outcomes, and identification of high-risk subgroups

Journal Article

Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Caron, P. C.; Falchi, L.; Hamilton, A.; more...
Blood Cancer Journal (2020)

Fulltext@MSK | Save

Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants

Journal Article

Cordeiro, P. G.; Ghione, P.; Ni, A.; Hu, Q.; Ganesan, N.; Galasso, N.; Dogan, A.; Horwitz, S. M.
Journal of Plastic Reconstructive and Aesthetic Surgery (2020)

Fulltext@MSK | Save

A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed stage IV squamous cell lung cancers

Journal Article

Paik, P. K.; Kim, R. K.; Ahn, L.; Plodkowski, A. J.; Ni, A.; Donoghue, M. T. A.; Jonsson, P.; Villalona-Calero, M.; Ng, K.; McFarland, D.; more...
Clinical Cancer Research (2020)

Fulltext@MSK | Save

V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma

Journal Article

Muller, S.; Lai, W. V.; Adusumilli, P. S.; Desmeules, P.; Frosina, D.; Jungbluth, A.; Ni, A.; Eguchi, T.; Travis, W. D.; Ladanyi, M.; more...
Modern Pathology (2020)

Fulltext@MSK | Save

Incidence of infectious complications with the combination of bendamustine and an anti-CD20 monoclonal antibody

Journal Article

Sarlo, K. M.; Dixon, B. N.; Ni, A.; Straus, D. J.
Leukemia and Lymphoma (2020)

Fulltext@MSK | Save